No Data
Express News | Nxtc Announces Replay Available for Virtual Kol Event Discussing Asco 2026 Dose Escalation Data From Phase 1 Trial of Sim0505 for Gynecologic Cancers
What's Going On With NextCure Stock Wednesday?
Lucid Capital Maintains NextCure(NXTC.US) With Buy Rating, Maintains Target Price $25
NextCure Share Weakness Overdone, Says Lucid Capital
12 Health Care Stocks Moving In Monday's Intraday Session
NextCure Reports Positive SIM0505 Phase 1 Gynecologic Cancer Data